Riskpilot← Back to searchSign inGet full accessPETOSAN AS
ASActiveOrg 984351984Unnelandsvegen 258, 5268 HaukelandManufacture of medical and dental instruments and supplies · NACE 3250Est. 20021 employeespetosan.com
Revenue 2024
NOK 7,1M
-10% vs 2023
EBITDA margin
10.3%
-7% vs 2023
Equity ratio
13.5%
Financial strength
Net profit 2024
NOK -460K
-29% vs 2023
| Revenue | NOK 7,1M | -10% |
| EBITDA | NOK 728K | -7% |
| Net profit | NOK -460K | -29% |
| Total assets | NOK 15,5M | -5% |
| Equity | NOK 2,1M | -18% |
| Employees | 1 | — |
Legal name
PETOSAN AS
Org number
984351984
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
9. april 2002
Share capital
NOK 138 100
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.daglig leder alene.
Company purpose
Utvikling, produksjon og salg av dentale produkter og tjenester.
Address
Unnelandsvegen 258, 5268 Haukeland
Website
petosan.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 3 055 | 4 758 | 4 331 | 4 469 | 4 352 | 4 043 | 4 345 | 4 663 | 5 115 | 6 209 | 5 243 | 5 441 | 6 562 | 7 218 | 6 566 | 7 841 | 7 051 |
| Staff expenses | −0 | −286 | −294 | −64 | −280 | −126 | −145 | −122 | −58 | −73 | −199 | 76 | 271 | 81 | −1 013 | −610 | −1 633 | −1 245 |
| EBITDA | 0 | 366 | −330 | 568 | 859 | 398 | 809 | 424 | 1 501 | 1 493 | 1 387 | 1 106 | 1 272 | 1 124 | −1 138 | 1 053 | 780 | 728 |
| Depreciation & amort. | −0 | −254 | −296 | −307 | −303 | −525 | −574 | −367 | −665 | −675 | −657 | −569 | −521 | −470 | −736 | −505 | −680 | −680 |
| EBIT | 0 | 111 | −626 | 261 | 556 | −127 | 235 | 56 | 835 | 819 | 731 | 537 | 750 | 653 | −1 874 | 548 | 99 | 48 |
| Net financials | 0 | −109 | −98 | −133 | −103 | −159 | −203 | −238 | −227 | −273 | −211 | −235 | −292 | −290 | −321 | −521 | −557 | −637 |
| Profit before tax | 0 | 2 | −724 | 128 | 453 | −286 | 32 | −181 | 608 | 545 | 519 | 302 | 458 | 363 | −2 195 | 27 | −458 | −590 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | 239 | 57 | 105 | −58 | −557 | 7 | −101 | −130 |
| Net profit | 0 | 2 | −724 | 128 | 453 | −286 | 32 | −181 | 608 | 545 | 280 | 246 | 353 | 421 | −1 639 | 21 | −357 | −460 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 4 013 | 4 820 | 5 527 | 6 427 | 8 428 | 8 524 | 10 154 | 11 875 | 12 305 | 15 302 | 16 438 | 16 089 | 16 151 | 15 039 | 16 776 | 16 353 | 15 497 |
| Equity | — | 44 | −680 | 649 | 1 102 | 816 | 847 | 1 666 | 2 274 | 2 820 | 3 100 | 3 845 | 4 198 | 4 619 | 2 891 | 2 912 | 2 555 | 2 095 |
| Long-term debt | 0 | 3 470 | 0 | 0 | 0 | 4 161 | 5 424 | 5 216 | 7 902 | 8 327 | 8 737 | 8 250 | 8 817 | 8 886 | 9 161 | 11 722 | 12 158 | 10 619 |
| Short-term debt | 0 | 499 | 1 047 | 972 | 1 722 | 3 451 | 2 252 | 3 272 | 1 698 | 1 158 | 3 465 | 4 342 | 3 074 | 2 646 | 2 987 | 2 142 | 1 640 | 2 783 |
| Total debt | 0 | 3 969 | 5 500 | 4 879 | 5 325 | 7 612 | 7 677 | 8 488 | 9 600 | 9 485 | 12 202 | 12 593 | 11 891 | 11 532 | 12 148 | 13 864 | 13 798 | 13 402 |
EBITDA margin
10.3%
This company
15.8%
Market median
-35% vs market
20072024
Equity ratio
13.5%
This company
38.2%
Market median
-65% vs market
20072024
Return on equity
-22.0%
This company
18.4%
Market median
-220% vs market
20072024
Net profit margin
-6.5%
This company
8.1%
Market median
-180% vs market
20072024
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20072024
Debt / equity
6.40×
This company
0.62×
Market median
-932% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OB Chief Executive Officer | Chief Executive Officer | 2002 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Sanoral As | Company | 8.0% | 8.0% | 2022 |
Dentaco As | Company | 7.2% | 7.2% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dentaco As
PETOSAN AS Board members of PETOSAN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Barman | Chief Executive Officer | 0 companies |
| Merete Barman | Board of Directors | 0 companies |
| Anne Hasselgreen | Board of Directors | 0 companies |
| Richard Stuart Godfrey | Chairman | 0 companies |